收费全文 | 7756篇 |
免费 | 645篇 |
国内免费 | 29篇 |
耳鼻咽喉 | 45篇 |
儿科学 | 296篇 |
妇产科学 | 151篇 |
基础医学 | 888篇 |
口腔科学 | 103篇 |
临床医学 | 1105篇 |
内科学 | 1380篇 |
皮肤病学 | 104篇 |
神经病学 | 623篇 |
特种医学 | 263篇 |
外科学 | 897篇 |
综合类 | 168篇 |
一般理论 | 8篇 |
预防医学 | 950篇 |
眼科学 | 204篇 |
药学 | 530篇 |
中国医学 | 23篇 |
肿瘤学 | 692篇 |
2023年 | 44篇 |
2022年 | 76篇 |
2021年 | 160篇 |
2020年 | 92篇 |
2019年 | 160篇 |
2018年 | 161篇 |
2017年 | 121篇 |
2016年 | 161篇 |
2015年 | 184篇 |
2014年 | 211篇 |
2013年 | 385篇 |
2012年 | 477篇 |
2011年 | 517篇 |
2010年 | 288篇 |
2009年 | 229篇 |
2008年 | 446篇 |
2007年 | 483篇 |
2006年 | 463篇 |
2005年 | 448篇 |
2004年 | 472篇 |
2003年 | 434篇 |
2002年 | 351篇 |
2001年 | 194篇 |
2000年 | 155篇 |
1999年 | 137篇 |
1998年 | 89篇 |
1997年 | 76篇 |
1996年 | 69篇 |
1995年 | 59篇 |
1994年 | 49篇 |
1993年 | 53篇 |
1992年 | 75篇 |
1991年 | 89篇 |
1990年 | 53篇 |
1989年 | 65篇 |
1988年 | 60篇 |
1987年 | 69篇 |
1986年 | 43篇 |
1985年 | 63篇 |
1984年 | 46篇 |
1983年 | 53篇 |
1982年 | 47篇 |
1981年 | 39篇 |
1980年 | 41篇 |
1978年 | 36篇 |
1977年 | 42篇 |
1976年 | 29篇 |
1975年 | 32篇 |
1974年 | 29篇 |
1972年 | 34篇 |
Interstitial lung disease (ILD) represents a significant cause of morbidity and mortality in systemic sclerosis (SSc). The purpose of this study was to examine recirculating lymphocytes from SSc patients for potential biomarkers of interstitial lung disease (ILD). Peripheral blood mononuclear cells (PBMCs) were isolated from patients with SSc and healthy controls enrolled in the Vanderbilt University Myositis and Scleroderma Treatment Initiative Center cohort between 9/2017–6/2019. Clinical phenotyping was performed by chart abstraction. Immunophenotyping was performed using both mass cytometry and fluorescence cytometry combined with t-distributed stochastic neighbor embedding analysis and traditional biaxial gating. This study included 34 patients with SSc-ILD, 14 patients without SSc-ILD, and 25 healthy controls. CD21lo/neg cells are significantly increased in SSc-ILD but not in SSc without ILD (15.4 ± 13.3% vs. 5.8 ± 0.9%, p = 0.002) or healthy controls (5.0 ± 0.5%, p < 0.0001). While CD21lo/neg B cells can be identified from a single biaxial gate, tSNE analysis reveals that the biaxial gate is comprised of multiple distinct subsets, all of which are increased in SSc-ILD. CD21lo/neg cells in both healthy controls and SSc-ILD are predominantly tBET positive and do not have intracellular CD21. Immunohistochemistry staining demonstrated that CD21lo/neg B cells diffusely infiltrate the lung parenchyma of an SSc-ILD patient. Additional work is needed to validate this biomarker in larger cohorts and longitudinal studies and to understand the role of these cells in SSc-ILD.
相似文献In order to offer early and accessible treatment for adolescents with depression, brief and effective treatments in adolescents’ everyday surroundings are needed. This randomized controlled trial studied the preliminary effectiveness, feasibility, and acceptability of interpersonal counseling (IPC) and brief psychosocial support (BPS) in school health and welfare services. The study was conducted in the 28 lower secondary schools of a large city in Southern Finland, randomized to provide either IPC or BPS. Help-seeking 12–16-year-old adolescents with mild-to-moderate depression, with and without comorbid anxiety, were included in the study. Fifty-five adolescents received either 6 weekly sessions of IPC or BPS and two follow-up sessions. Outcome measures included self- and clinician-rated measures of depression, global functioning, and psychological distress/well-being. To assess feasibility and acceptability of the treatments, adolescents’ and counselors’ treatment compliance and satisfaction with treatment were assessed. Both treatments were effective in reducing depressive disorders and improving adolescents’ overall functioning and well-being. At post-treatment, in both groups, over 50% of adolescents achieved recovery based on self-report and over 70% based on observer report. Effect sizes for change were medium or large in both groups at post-treatment and increased at 6-month follow-up. A trend indicating greater baseline symptom severity among adolescents treated in the IPC-providing schools was observed. Adolescents and counselors in both groups were satisfied with the treatment, and 89% of the adolescents completed the treatments and follow-ups. This trial suggests that both IPC and BPS are feasible, acceptable, and effective treatments for mild-to-moderate depression in the school setting. In addition, IPC seems effective even if comorbid anxiety exists. Our study shows that brief, structured interventions, such as IPC and BPS, are beneficial in treating mild-to-moderate depression in school settings and can be administered by professionals working at school.
Trial registrationhttp://www.clinicaltrials.gov. Unique identifier: NCT03001245.
相似文献![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)